The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients (pts) with platinum-agnostic ovarian cancer: Final analysis.
 
David M. O'Malley
No Relationships to Disclose
 
Ana Oaknin
No Relationships to Disclose
 
Ursula A. Matulonis
No Relationships to Disclose
 
Gina Mantia-Smaldone
No Relationships to Disclose
 
Peter C Lim
No Relationships to Disclose
 
Cesar Martin Castro
No Relationships to Disclose
 
Diane M. Provencher
No Relationships to Disclose
 
Sanaz Memarzadeh
No Relationships to Disclose
 
Patrick A. Zweidler-McKay
No Relationships to Disclose
 
Jiuzhou Wang
No Relationships to Disclose
 
Brooke Esteves
No Relationships to Disclose
 
Kathleen N. Moore
No Relationships to Disclose
 
Lucy Gilbert
No Relationships to Disclose